167 related articles for article (PubMed ID: 32081930)
1. Selection and validation of miR-1280 as a suitable endogenous normalizer for qRT-PCR Analysis of serum microRNA expression in Hepatocellular Carcinoma.
Pratama MY; Cavalletto L; Tiribelli C; Chemello L; Pascut D
Sci Rep; 2020 Feb; 10(1):3128. PubMed ID: 32081930
[TBL] [Abstract][Full Text] [Related]
2. Assessment of endogenous reference gene suitability for serum exosomal microRNA expression analysis in liver carcinoma resection studies.
Li Y; Xiang GM; Liu LL; Liu C; Liu F; Jiang DN; Pu XY
Mol Med Rep; 2015 Sep; 12(3):4683-4691. PubMed ID: 26082194
[TBL] [Abstract][Full Text] [Related]
3. Different normalization strategies might cause inconsistent variation in circulating microRNAs in patients with hepatocellular carcinoma.
Tang G; Shen X; Lv K; Wu Y; Bi J; Shen Q
Med Sci Monit; 2015 Feb; 21():617-24. PubMed ID: 25719241
[TBL] [Abstract][Full Text] [Related]
4. Identification and validation of miRNAs as endogenous controls for RQ-PCR in blood specimens for breast cancer studies.
McDermott AM; Kerin MJ; Miller N
PLoS One; 2013; 8(12):e83718. PubMed ID: 24391813
[TBL] [Abstract][Full Text] [Related]
5. Circulating miRNA-199a and miRNA-122 Levels as Potential Diagnostic and Prognostic Biomarkers for Hepatocellular Carcinoma.
Wu J; Wu Y; Luo Y; Li X; Lin N; Yang X; Lin Y; Chen M
Ann Clin Lab Sci; 2020 Mar; 50(2):219-227. PubMed ID: 32366560
[TBL] [Abstract][Full Text] [Related]
6. Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection.
Qi P; Cheng SQ; Wang H; Li N; Chen YF; Gao CF
PLoS One; 2011; 6(12):e28486. PubMed ID: 22174818
[TBL] [Abstract][Full Text] [Related]
7. Early-phase circulating miRNAs predict tumor recurrence and survival of hepatocellular carcinoma patients after liver transplantation.
Ng KT; Lo CM; Wong N; Li CX; Qi X; Liu XB; Geng W; Yeung OW; Ma YY; Chan SC; Man K
Oncotarget; 2016 Apr; 7(15):19824-39. PubMed ID: 26918346
[TBL] [Abstract][Full Text] [Related]
8. Serum MicroRNAs as Biomarkers in Hepatitis C: Preliminary Evidence of a MicroRNA Panel for the Diagnosis of Hepatocellular Carcinoma.
Weis A; Marquart L; Calvopina DA; Genz B; Ramm GA; Skoien R
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781550
[TBL] [Abstract][Full Text] [Related]
9. Novel serum microRNAs panel on the diagnostic and prognostic implications of hepatocellular carcinoma.
An Y; Gao S; Zhao WC; Qiu BA; Xia NX; Zhang PJ; Fan ZP
World J Gastroenterol; 2018 Jun; 24(24):2596-2604. PubMed ID: 29962816
[TBL] [Abstract][Full Text] [Related]
10. A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study.
Lin XJ; Chong Y; Guo ZW; Xie C; Yang XJ; Zhang Q; Li SP; Xiong Y; Yuan Y; Min J; Jia WH; Jie Y; Chen MS; Chen MX; Fang JH; Zeng C; Zhang Y; Guo RP; Wu Y; Lin G; Zheng L; Zhuang SM
Lancet Oncol; 2015 Jul; 16(7):804-15. PubMed ID: 26088272
[TBL] [Abstract][Full Text] [Related]
11. Validation of a serum microRNA panel as biomarkers for early diagnosis of hepatocellular carcinoma post-hepatitis C infection in Egyptian patients.
Elemeery MN; Badr AN; Mohamed MA; Ghareeb DA
World J Gastroenterol; 2017 Jun; 23(21):3864-3875. PubMed ID: 28638226
[TBL] [Abstract][Full Text] [Related]
12. Normalization matters: tracking the best strategy for sperm miRNA quantification.
Corral-Vazquez C; Blanco J; Salas-Huetos A; Vidal F; Anton E
Mol Hum Reprod; 2017 Jan; 23(1):45-53. PubMed ID: 27932553
[TBL] [Abstract][Full Text] [Related]
13. Expression Analysis of Serum microRNA-34a and microRNA-183 in Hepatocellular Carcinoma.
Bharali D; Jebur HB; Baishya D; Kumar S; Sarma MP; Masroor M; Akhter J; Husain SA; Kar P
Asian Pac J Cancer Prev; 2018 Sep; 19(9):2561-2568. PubMed ID: 30256056
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer.
Wang L; Liu Y; Du L; Li J; Jiang X; Zheng G; Qu A; Wang H; Wang L; Zhang X; Liu H; Pan H; Yang Y; Wang C
Mol Med Rep; 2015 Jul; 12(1):615-22. PubMed ID: 25738263
[TBL] [Abstract][Full Text] [Related]
15. Serum microRNA 143 and microRNA 215 as potential biomarkers for the diagnosis of chronic hepatitis and hepatocellular carcinoma.
Zhang ZQ; Meng H; Wang N; Liang LN; Liu LN; Lu SM; Luan Y
Diagn Pathol; 2014 Jul; 9():135. PubMed ID: 24993656
[TBL] [Abstract][Full Text] [Related]
16. Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients.
Motawi TK; Shaker OG; El-Maraghy SA; Senousy MA
PLoS One; 2015; 10(9):e0137706. PubMed ID: 26352740
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of serum microRNAs in cirrhosis that evolve into hepatocellular carcinoma related to hepatitis B virus.
Tan Y; Lin B; Ye Y; Wen D; Chen L; Zhou X
Oncol Rep; 2015 Jun; 33(6):2863-70. PubMed ID: 25962820
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP
Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037
[TBL] [Abstract][Full Text] [Related]
19. Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissues.
Bignotti E; Calza S; Tassi RA; Zanotti L; Bandiera E; Sartori E; Odicino FE; Ravaggi A; Todeschini P; Romani C
J Cell Mol Med; 2016 Dec; 20(12):2341-2348. PubMed ID: 27419385
[TBL] [Abstract][Full Text] [Related]
20. Circulating miR-148/152 family as potential biomarkers in hepatocellular carcinoma.
Wang F; Ying H; He B; Pan Y; Sun H; Wang S
Tumour Biol; 2016 Apr; 37(4):4945-53. PubMed ID: 26531720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
